News & AnalysisBiofidelity fetches $23mBiofidelity, a provider of precision cancer diagnostics, has raised $23 million in funding.ByIris Dorbian1 February 2022•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs